Single cell profiling of phospho-protein levels in chronic lymphocytic leukemia.

about

Single cell profiling of phospho-protein levels in chronic lymphocytic leukemia.

Item

http://www.wikidata.org/entity/Q54261746

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Single cell profiling of phospho-protein levels in chronic lymphocytic leukemia.

@en

Single cell profiling of phospho-protein levels in chronic lymphocytic leukemia.

@nl

type

Item

label

Single cell profiling of phospho-protein levels in chronic lymphocytic leukemia.

@en

Single cell profiling of phospho-protein levels in chronic lymphocytic leukemia.

@nl

prefLabel

Single cell profiling of phospho-protein levels in chronic lymphocytic leukemia.

@en

Single cell profiling of phospho-protein levels in chronic lymphocytic leukemia.

@nl

P1476

Single cell profiling of phospho-protein levels in chronic lymphocytic leukemia.

@en

P2093

Andrea Cremaschi

http://www.w3.org/2001/XMLSchema#string

Geir E Tjønnfjord

http://www.w3.org/2001/XMLSchema#string

Ida K Myhrvold

http://www.w3.org/2001/XMLSchema#string

Johanne U Hermansen

http://www.w3.org/2001/XMLSchema#string

Ludvig A Munthe

http://www.w3.org/2001/XMLSchema#string

P2860

STATs in cancer inflammation and immunity: a leading role for STAT3

Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities.

Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase

B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression

The JAK/STAT signaling pathway.

Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma

Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors.

Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells.

Outcome of advanced chronic lymphocytic leukemia following different first-line and relapse therapies: a meta-analysis of five prospective trials by the German CLL Study Group (GCLLSG).

B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues.

P304

9273-9284

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.23949

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kjetil Taskén

Sigrid S Skånland

P577

2018-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29507689

http://www.w3.org/2001/XMLSchema#string

P921

lymphocyte

P932

5823631

http://www.w3.org/2001/XMLSchema#string